Rhabdomyolysis and Renal Injury With Lovastatin Use: Report of Two Cases in Cardiac Transplant Recipients

JAMA: The Journal of the American Medical Association

Volumn 260, Issue 2, 1988, Pages 239-241

  Corpier, Cindy L ^a   Jones, Peter H ^a   Suki, Wadi N ^a   Lederer, Eleanor D ^a   Quinones, Miguel A ^a   Schmidt, Shelley W ^a   Young, James B ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CIMETIDINE; CYCLOSPORIN A; ERYTHROMYCIN; FUROSEMIDE; MANNITOL; MEVINOLIN; NIFEDIPINE; PREDNISONE; QUININE; SALBUTAMOL;

ACUTE KIDNEY FAILURE; CLINICAL ARTICLE; HEART TRANSPLANTATION; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RHABDOMYOLYSIS;

ADULT; CASE REPORT; CREATINE KINASE; HEART TRANSPLANTATION; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY FAILURE, ACUTE; LEGIONELLOSIS; LOVASTATIN; MALE; MIDDLE AGE; RHABDOMYOLYSIS;

EID: 0023929374     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1988.03410020105038     Document Type: Article

References (13)

1. Alonso DR, Starek PK, Minick CR: Studies on the pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia. Am J Pathol 1977;87:415-442.
2. Hess ML, Hastillo A, Mohanakumar T, et al.: Accelerated atherosclerosis in cardiac transplantation: Role of cytotoxic B-cell antibodies and hyperlipidemia. Circulation 1983;68(suppl 2):94-101.
3. Becker DM, Markakis M, Sension M, et al.: Hyperlipidemia and hypertension following heart transplantation: Potential causes of coronary atherosclerosis, abstracted. J Am Coll Cardiol 1986;7:9A.
4. The Lovastatin Study Group II: Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia: A multicenter study. JAMA 1986;256:2829-2834.
5. Tobert JA, Hitzenberger G, Kukovetz WR, et al.: Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase. Atherosclerosis 1982;41:61-65.
6. Tobert JA, Bell GO, Birtwell J, et al.: Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, in healthy volunteers. J Clin Invest 1982;69:913-919.
7. Ballantyne CM, Jones PH, Payton-Ross C, et al.: Hyperlipidemia following heart transplantation: Natural history and intervention with mevinolin (lovastatin). Transplant Proc 1987;19:60-62.
8. Cohen DJ, Loertscher R, Rubio MF, et al.: Cyclosporine: A new immunosuppressive agent for organ transplantation. Ann Intern Med 1984;101:667-682.
9. Kirby BD, Snyder KM, Meyer RD, et al.: Legionnaires’ disease: Report of 65 nosocomially acquired cases and review of the literature. Medicine 1980;59:188-205.
10. Case 17-1978, Case records of the Massachusetts General Hospital: N Engl J Med 1978;298:1014-1021.
11. Friedman HM: Legionnaires’ disease in nonlegionnaires: A report of five cases. Ann Intern Med 1978;88:294-302.
12. Ferguson RM, Sutherland DER, Simmon RL, et al.: Ketoconazole, cyclosporine metabolism, and renal transplantation. Lancet 1982;2:882-883.
13. Vereerstraeten P, Thiry P, Kinnaert P, et al.: Influence of erythromycin on cyclosporine pharmacokinetics. Transplantation 1987;44:155-156.